vs
Side-by-side financial comparison of VAALCO ENERGY INC (EGY) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $91.0M, roughly 1.9× VAALCO ENERGY INC). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -25.2%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -4.7%).
VAALCO Energy is a company engaged in hydrocarbon exploration. It is organized in Delaware and headquartered in Houston, Texas with operations primarily in the Etame Marin block offshore Gabon.
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
EGY vs ESPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $91.0M | $168.4M |
| Net Profit | $-58.6M | — |
| Gross Margin | — | — |
| Operating Margin | -71.3% | 50.6% |
| Net Margin | -64.4% | — |
| Revenue YoY | -25.2% | 143.7% |
| Net Profit YoY | -602.5% | — |
| EPS (diluted) | $-0.56 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $91.0M | $168.4M | ||
| Q3 25 | $61.0M | $87.3M | ||
| Q2 25 | $96.9M | $82.4M | ||
| Q1 25 | $110.3M | $65.0M | ||
| Q4 24 | $121.7M | $69.1M | ||
| Q3 24 | $140.3M | $51.6M | ||
| Q2 24 | $116.8M | $73.8M | ||
| Q1 24 | $100.2M | $137.7M |
| Q4 25 | $-58.6M | — | ||
| Q3 25 | $1.1M | $-31.3M | ||
| Q2 25 | $8.4M | $-12.7M | ||
| Q1 25 | $7.7M | $-40.5M | ||
| Q4 24 | $11.7M | — | ||
| Q3 24 | $11.0M | $-29.5M | ||
| Q2 24 | $28.2M | $-61.9M | ||
| Q1 24 | $7.7M | $61.0M |
| Q4 25 | -71.3% | 50.6% | ||
| Q3 25 | 1.5% | -11.4% | ||
| Q2 25 | 17.7% | 8.6% | ||
| Q1 25 | 23.7% | -34.0% | ||
| Q4 24 | 32.7% | -6.4% | ||
| Q3 24 | 31.4% | -31.0% | ||
| Q2 24 | 17.5% | 3.5% | ||
| Q1 24 | 32.1% | 52.5% |
| Q4 25 | -64.4% | — | ||
| Q3 25 | 1.8% | -35.9% | ||
| Q2 25 | 8.6% | -15.4% | ||
| Q1 25 | 7.0% | -62.2% | ||
| Q4 24 | 9.6% | — | ||
| Q3 24 | 7.8% | -57.2% | ||
| Q2 24 | 24.1% | -83.9% | ||
| Q1 24 | 7.7% | 44.3% |
| Q4 25 | $-0.56 | $0.32 | ||
| Q3 25 | $0.01 | $-0.16 | ||
| Q2 25 | $0.08 | $-0.06 | ||
| Q1 25 | $0.07 | $-0.21 | ||
| Q4 24 | $0.12 | $-0.14 | ||
| Q3 24 | $0.10 | $-0.15 | ||
| Q2 24 | $0.27 | $-0.33 | ||
| Q1 24 | $0.07 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $58.9M | $167.9M |
| Total DebtLower is stronger | $60.0M | — |
| Stockholders' EquityBook value | $443.5M | $-302.0M |
| Total Assets | $913.4M | $465.9M |
| Debt / EquityLower = less leverage | 0.14× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $58.9M | $167.9M | ||
| Q3 25 | $24.0M | $92.4M | ||
| Q2 25 | $67.9M | $86.1M | ||
| Q1 25 | $40.9M | $114.6M | ||
| Q4 24 | $82.7M | $144.8M | ||
| Q3 24 | $89.1M | $144.7M | ||
| Q2 24 | $62.9M | $189.3M | ||
| Q1 24 | $113.3M | $226.6M |
| Q4 25 | $60.0M | — | ||
| Q3 25 | $60.0M | — | ||
| Q2 25 | $60.0M | — | ||
| Q1 25 | $0 | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | — | ||
| Q1 24 | $0 | — |
| Q4 25 | $443.5M | $-302.0M | ||
| Q3 25 | $505.9M | $-451.4M | ||
| Q2 25 | $511.6M | $-433.5M | ||
| Q1 25 | $504.1M | $-426.2M | ||
| Q4 24 | $501.6M | $-388.7M | ||
| Q3 24 | $501.0M | $-370.2M | ||
| Q2 24 | $493.6M | $-344.2M | ||
| Q1 24 | $472.6M | $-294.3M |
| Q4 25 | $913.4M | $465.9M | ||
| Q3 25 | $950.4M | $364.0M | ||
| Q2 25 | $964.9M | $347.1M | ||
| Q1 25 | $927.1M | $324.0M | ||
| Q4 24 | $955.0M | $343.8M | ||
| Q3 24 | $937.9M | $314.1M | ||
| Q2 24 | $917.4M | $352.3M | ||
| Q1 24 | $809.1M | $373.1M |
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $145.2M | $45.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $145.2M | $45.2M | ||
| Q3 25 | $16.4M | $-4.3M | ||
| Q2 25 | $18.3M | $-31.4M | ||
| Q1 25 | $32.7M | $-22.6M | ||
| Q4 24 | $44.5M | $-35.0M | ||
| Q3 24 | $47.8M | $-35.3M | ||
| Q2 24 | $-438.0K | $-7.2M | ||
| Q1 24 | $21.8M | $53.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $29.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-35.5M | ||
| Q2 24 | — | $-7.3M | ||
| Q1 24 | — | $53.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 26.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -68.7% | ||
| Q2 24 | — | -9.9% | ||
| Q1 24 | — | 39.0% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | 2.7% | 0.0% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 14.94× | — | ||
| Q2 25 | 2.19× | — | ||
| Q1 25 | 4.23× | — | ||
| Q4 24 | 3.82× | — | ||
| Q3 24 | 4.35× | — | ||
| Q2 24 | -0.02× | — | ||
| Q1 24 | 2.84× | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EGY
| Crude Oil Sales And Purchase Agreements | $54.8M | 60% |
| Other | $31.9M | 35% |
| Crude Oil | $3.0M | 3% |
| Natural Gas Liquids Reserves | $1.4M | 2% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
